一项新的血液测试通过测量特定蛋白质,准确地检测了80%以上的ALS。 A new blood test accurately detects ALS with over 80% success by measuring specific proteins.

一项新的血液测试显示,通过测量神经纤维素光链蛋白质,在精确度超过80%的急性子宫颈硬化(ALS)诊断过程中,有望进行新的血液测试。 A new blood test has shown promise in diagnosing Amyotrophic Lateral Sclerosis (ALS), with over 80% accuracy, by measuring neurofilament light chain proteins. 这些蛋白质在ALS病人体内呈上升趋势,可以帮助预测存活率和疾病发展。 These proteins are elevated in ALS patients and can help predict survival rates and disease progression. 这项研究比较了139名ALS病人和70名类似疾病的病人的验血结果,表明需要进一步研究来证实这些结果。 The study compared the blood test results of 139 ALS patients and 70 people with similar diseases, indicating that further research is needed to confirm these findings.